LATEST INNOVATIONS!
POWERDOT
P
owerDot works via a mobile app that uses
Electrical Muscle Stimulation (EMS) to
activate your muscle fibres, get your body’s
lymphatic system flowing and increase the
blood flow to targeted areas. Basically, it gets
you moving. The result is the creation of a
perfect environment for the body to recover
faster, feel better and over all well-being. It
also allows you to control your workout.
An impulse is sent to the pods based on the
muscle group you select to target which
causes the muscles to activate. The feeling
that it creates can be intense and bizarre
at first, but you will get used to it in a few
uses. It is also compact enough to carry on a
holiday or trip and is available from £275 at
PowerDot.
NEEDLE-FREE DIABETES CARE:
THE FUTURE OF DIABETES SELF-CARE
N
eedle-Free Diabetes Care is
a path-breaking technology
currently
under
development.
The best options available today
for automating most of the
complicated daily process of blood
sugar management are continuous
glucose monitors and insulin pumps
however they don’t completely
remove the need for skin pricks and
shots. The new skin in the game is a
technology being developed by Echo
Therapeutics (Philadelphia, USA)
that would replace the poke with
a patch. A transdermal biosensor
that reads blood analytes through
the skin without drawing blood is
what the company is aiming for. The
technology puts the patient’s blood
chemistry within signal range of a
patch-borne biosensor with the help
of a handheld electric-toothbrush
like device that removes just enough
top-layer skin cells. The sensor
32
Volume 3 | Issue 3 | July-September 2018
collects one reading per minute
and sends the data wirelessly to
a remote monitor. When levels go
out of the patient’s optimal range,
this triggers audible alarms thus
tracking glucose levels over time.
There are other start-ups working in
the same space as GlucoSense, a spin-
out of the University of Leeds funded
by NetScientific is developing a
non-invasive device based on
photonics technology. Another
Dutch start-up called NovioSenseis
working on an implantable glucose
sensor that uses tear fluid to
measure glucose levels.